相似文献
1
Prolactinoma and pregnancy.
BJOG. 2000 Sep;107(9):1064-8. doi: 10.1111/j.1471-0528.2000.tb11101.x.
2
Diagnosis and treatment of prolactinomas.
Adv Intern Med. 1999;44:117-53.
3
[Prolactinoma and pregnancy].
Akush Ginekol (Sofiia). 2004;43 Suppl 2:16-22.
4
[Quinagolide and macroprolactinomas a progress?].
Ann Endocrinol (Paris). 1997;58(2):83-5.
5
Relative resistance of a macroprolactinoma to bromocriptine therapy during pregnancy.
Gynecol Endocrinol. 1996 Apr;10(2):91-4. doi: 10.3109/09513599609097897.
6
[Management of pituitary adenoma in pregnancy].
Zhonghua Fu Chan Ke Za Zhi. 1996 Sep;31(9):537-9.
7
Prolactin, prolactin disorders, and dopamine agonists during pregnancy.
Hormones (Athens). 2019 Jun;18(2):137-139. doi: 10.1007/s42000-018-0071-z. Epub 2018 Oct 19.
8
Cabergoline treatment of pregnant women with macroprolactinomas.
Int J Gynaecol Obstet. 2007 Oct;99(1):61-2. doi: 10.1016/j.ijgo.2007.04.027. Epub 2007 Jun 28.
9
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
Endocrinol Nutr. 2015 Apr;62(4):200-2. doi: 10.1016/j.endonu.2015.01.007. Epub 2015 Feb 26.
10
[Use of bromocriptine during pregnancy and appearance of partial empty sella turcica in women with prolactinoma].
Rev Clin Esp. 1991 Nov;189(7):343-4.
引用本文的文献
1
Visual loss in pregnancy.
BMJ Case Rep. 2019 May 5;12(5):e228323. doi: 10.1136/bcr-2018-228323.
2
Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.
Physiol Genomics. 2018 Mar 1;50(3):215-234. doi: 10.1152/physiolgenomics.00105.2017. Epub 2018 Jan 26.
Zotero 插件